Encompass Health Corp Net Income
| EHC Stock | USD 114.68 1.25 1.10% |
As of the 12th of February 2026, Encompass Health shows the Mean Deviation of 1.07, coefficient of variation of (21,635), and Standard Deviation of 1.56. Encompass Health Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Encompass Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.2816 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 567.2 M | 595.6 M | |
| Net Income Applicable To Common Shares | 520.8 M | 313.3 M | |
| Net Income From Continuing Ops | 689.3 M | 445 M | |
| Net Income Per Share | 5.63 | 5.92 | |
| Net Income Per E B T | 0.59 | 0.54 |
Encompass | Net Income | Build AI portfolio with Encompass Stock |
Analyzing Encompass Health's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Encompass Health's current valuation and future prospects.
Latest Encompass Health's Net Income Growth Pattern
Below is the plot of the Net Income of Encompass Health Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Encompass Health Corp financial statement analysis. It represents the amount of money remaining after all of Encompass Health Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Encompass Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Encompass Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 567.2 M | 10 Years Trend |
|
Net Income |
| Timeline |
Encompass Net Income Regression Statistics
| Arithmetic Mean | 307,435,882 | |
| Coefficient Of Variation | 47.22 | |
| Mean Deviation | 107,159,862 | |
| Median | 284,200,000 | |
| Standard Deviation | 145,159,404 | |
| Sample Variance | 21071.3T | |
| Range | 596M | |
| R-Value | 0.86 | |
| Mean Square Error | 5870.8T | |
| R-Squared | 0.74 | |
| Slope | 24,708,039 | |
| Total Sum of Squares | 337140T |
Encompass Net Income History
Other Fundumenentals of Encompass Health Corp
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Encompass Health Net Income component correlations
Encompass Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Encompass Health is extremely important. It helps to project a fair market value of Encompass Stock properly, considering its historical fundamentals such as Net Income. Since Encompass Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Encompass Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Encompass Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Providers & Services sector continue expanding? Could Encompass diversify its offerings? Factors like these will boost the valuation of Encompass Health. Projected growth potential of Encompass fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Encompass Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.208 | Dividend Share 0.72 | Earnings Share 5.77 | Revenue Per Share | Quarterly Revenue Growth 0.099 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Encompass Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Encompass Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Encompass Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Encompass Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Encompass Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Encompass Health.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Encompass Health on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Encompass Health Corp or generate 0.0% return on investment in Encompass Health over 90 days. Encompass Health is related to or competes with Ensign, Align Technology, AptarGroup, Bio Rad, Chemed Corp, Molina Healthcare, and Revolution Medicines. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States More
Encompass Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Encompass Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Encompass Health Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 6.16 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 2.7 |
Encompass Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Encompass Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Encompass Health's standard deviation. In reality, there are many statistical measures that can use Encompass Health historical prices to predict the future Encompass Health's volatility.| Risk Adjusted Performance | 0.0012 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.20) | |||
| Treynor Ratio | (0.03) |
Encompass Health February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0012 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.07 | |||
| Coefficient Of Variation | (21,635) | |||
| Standard Deviation | 1.56 | |||
| Variance | 2.42 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.20) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 6.16 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 2.7 | |||
| Skewness | 1.2 | |||
| Kurtosis | 3.15 |
Encompass Health Corp Backtested Returns
At this point, Encompass Health is very steady. Encompass Health Corp secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of standard deviation over the last 3 months. We have found twenty-three technical indicators for Encompass Health Corp, which you can use to evaluate the volatility of the firm. Please confirm Encompass Health's Standard Deviation of 1.56, coefficient of variation of (21,635), and Mean Deviation of 1.07 to check if the risk estimate we provide is consistent with the expected return of 0.0154%. The firm shows a Beta (market volatility) of 0.64, which means possible diversification benefits within a given portfolio. As returns on the market increase, Encompass Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Encompass Health is expected to be smaller as well. Encompass Health Corp right now shows a risk of 1.63%. Please confirm Encompass Health Corp coefficient of variation, treynor ratio, skewness, as well as the relationship between the jensen alpha and value at risk , to decide if Encompass Health Corp will be following its price patterns.
Auto-correlation | 0.52 |
Modest predictability
Encompass Health Corp has modest predictability. Overlapping area represents the amount of predictability between Encompass Health time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Encompass Health Corp price movement. The serial correlation of 0.52 indicates that about 52.0% of current Encompass Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 23.42 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Encompass Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Encompass Health Corp reported net income of 567.2 M. This is 66.2% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. This indicator is about the same for all United States stocks average (which is currently at 5.7097980139E8).
Encompass Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Encompass Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Encompass Health could also be used in its relative valuation, which is a method of valuing Encompass Health by comparing valuation metrics of similar companies.Encompass Health is currently under evaluation in net income category among its peers.
Encompass Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Encompass Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Encompass Health's managers, analysts, and investors.Environmental | Governance | Social |
Encompass Health Institutional Holders
Institutional Holdings refers to the ownership stake in Encompass Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Encompass Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Encompass Health's value.| Shares | T. Rowe Price Associates, Inc. | 2025-06-30 | 1.4 M | William Blair Investment Management, Llc | 2025-06-30 | 1.4 M | Jpmorgan Chase & Co | 2025-06-30 | 1.3 M | Norges Bank | 2025-06-30 | 1.1 M | Brown Advisory Holdings Inc | 2025-06-30 | 1.1 M | Td Global Investment Solutions – Td Epoch | 2025-06-30 | 1.1 M | Northern Trust Corp | 2025-06-30 | 1.1 M | Bank Of New York Mellon Corp | 2025-06-30 | 1 M | Arrowstreet Capital Limited Partnership | 2025-06-30 | 1 M | Vanguard Group Inc | 2025-06-30 | 10.4 M | Blackrock Inc | 2025-06-30 | 9.9 M |
Encompass Fundamentals
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.0966 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 13.54 B | ||||
| Shares Outstanding | 100 M | ||||
| Shares Owned By Insiders | 1.41 % | ||||
| Shares Owned By Institutions | 98.32 % | ||||
| Number Of Shares Shorted | 4.3 M | ||||
| Price To Earning | 18.73 X | ||||
| Price To Book | 4.47 X | ||||
| Price To Sales | 1.92 X | ||||
| Revenue | 5.94 B | ||||
| Gross Profit | 2.56 B | ||||
| EBITDA | 1.21 B | ||||
| Net Income | 567.2 M | ||||
| Cash And Equivalents | 85.4 M | ||||
| Cash Per Share | 0.60 X | ||||
| Total Debt | 266.7 M | ||||
| Debt To Equity | 1.69 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | 24.38 X | ||||
| Cash Flow From Operations | 1.18 B | ||||
| Short Ratio | 3.77 X | ||||
| Earnings Per Share | 5.77 X | ||||
| Price To Earnings To Growth | 1.37 X | ||||
| Target Price | 142.73 | ||||
| Number Of Employees | 42.3 K | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 11.41 B | ||||
| Total Asset | 7.09 B | ||||
| Retained Earnings | 796.7 M | ||||
| Working Capital | 45.9 M | ||||
| Current Asset | 659.58 M | ||||
| Current Liabilities | 474.74 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.65 % | ||||
| Net Asset | 7.09 B | ||||
| Last Dividend Paid | 0.72 |
About Encompass Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Encompass Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Encompass Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Encompass Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Health Care Providers & Services sector continue expanding? Could Encompass diversify its offerings? Factors like these will boost the valuation of Encompass Health. Projected growth potential of Encompass fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Encompass Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.208 | Dividend Share 0.72 | Earnings Share 5.77 | Revenue Per Share | Quarterly Revenue Growth 0.099 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Encompass Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Encompass Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Encompass Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.